Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd C Kieseier

Showing results (1-10 of 259) with videos related to

Pageof 26
Sort By:
Expert Review of Neurotherapeutics|January 15, 2014
The challenges of measuring disability accumulation in relapsing-remitting multiple sclerosis: evidence from interferon beta treatmentsBernd C Kieseier
CNS Drugs|June 9, 2011
The mechanism of action of interferon-β in relapsing multiple sclerosisBernd C Kieseier
Therapeutic Advances in Neurological Disorders|July 9, 2014
Defining a role for laquinimod in multiple sclerosisBernd C Kieseier
Acta Neuropathologica|July 1, 2015
Nrf2 and beyond: deciphering the mode of action of fumarates in the inflamed central nervous systemBernd C Kieseier, Heinz Wiendl
Neurology and Therapy|May 23, 2015
Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosisBernd C Kieseier, Myriam Benamor
The Lancet. Neurology|May 17, 2011
Transforming multiple sclerosis trials into practical realityBernd C Kieseier, Heinz Wiendl
Nature Reviews. Neurology|April 7, 2011
A critical appraisal of treatment decisions in multiple sclerosis--old versus newBernd C Kieseier, Olaf Stüve
The Lancet. Neurology|December 20, 2005
Multiple sclerosis: advances, excitements, disenchantmentsBernd C Kieseier, Heinz Wiendl
Neurology|August 4, 2010
Postpartum disease activity and breastfeeding in multiple sclerosis revisitedBernd C Kieseier, Heinz Wiendl
Journal of Neurology|September 26, 2006
Therapy of immune neuropathies with intravenous immunoglobulinsRalf Gold, Bernd C Kieseier
Pageof 26

Showing results (1-10 of 259) with videos related to

Sort By:
Pageof 26
Expert Review of Neurotherapeutics|January 15, 2014
The challenges of measuring disability accumulation in relapsing-remitting multiple sclerosis: evidence from interferon beta treatmentsBernd C Kieseier
CNS Drugs|June 9, 2011
The mechanism of action of interferon-β in relapsing multiple sclerosisBernd C Kieseier
Therapeutic Advances in Neurological Disorders|July 9, 2014
Defining a role for laquinimod in multiple sclerosisBernd C Kieseier
Acta Neuropathologica|July 1, 2015
Nrf2 and beyond: deciphering the mode of action of fumarates in the inflamed central nervous systemBernd C Kieseier, Heinz Wiendl
Neurology and Therapy|May 23, 2015
Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosisBernd C Kieseier, Myriam Benamor
The Lancet. Neurology|May 17, 2011
Transforming multiple sclerosis trials into practical realityBernd C Kieseier, Heinz Wiendl
Nature Reviews. Neurology|April 7, 2011
A critical appraisal of treatment decisions in multiple sclerosis--old versus newBernd C Kieseier, Olaf Stüve
The Lancet. Neurology|December 20, 2005
Multiple sclerosis: advances, excitements, disenchantmentsBernd C Kieseier, Heinz Wiendl
Neurology|August 4, 2010
Postpartum disease activity and breastfeeding in multiple sclerosis revisitedBernd C Kieseier, Heinz Wiendl
Journal of Neurology|September 26, 2006
Therapy of immune neuropathies with intravenous immunoglobulinsRalf Gold, Bernd C Kieseier
Pageof 26